Skip to main content
Equibles

Lingotto Investment Management LLP

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1732768 London, X0
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$8,098,445
-$9,958,490 QoQ
Shares Held
2,206,661
-62.5% QoQ
Ownership
0.412%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#27
of 344 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Lingotto Investment Management LLP holds $61,594,852 across 2 Biotechnology names. RXRX ranks #2 (13.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRNA
Moderna, Inc.
 763,907 $53,496,407
2 RXRX
Recursion Pharmaceuticals, Inc.
This page 		2,206,661 $8,098,445

All Filings in RXRX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,098,445 2,206,661
2026-03-31 $18,056,935 5,881,738
2025-12-31 $20,168,023 4,931,057
2025-09-30 $17,934,375 3,675,077
2025-06-30 $18,595,889 3,675,077
2025-03-31 $19,441,157 3,675,077
2024-12-31 $24,843,520 3,675,077
2024-09-30 $24,218,757 3,675,077
2024-06-30 $27,563,077 3,675,077
2024-03-31 $21,685,517 2,175,077
2023-12-31 $18,488,259 1,875,077
2023-09-30 $5,929,339 775,077
2023-06-30 $5,789,825 775,077